Medicina, Dermatología y Toxicología
Departamento
University of Alabama at Birmingham
Birmingham, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Alabama at Birmingham (4)
2022
2019
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
1996
-
Transesophageal echocardiographic assessment of papillary muscle rupture
Circulation, Vol. 94, Núm. 5, pp. 1003-1009